Joaquim José Coutinho Ferreira


AuthID: R-000-7JF

Publicações a aguardarem confirmação

481
TITLE: Eslicarbazepine acetate: a new option for the treatment of focal epilepsy
AUTHORS: Joaquim Ferreira; Tiago Mestre;
PUBLISHED: 2009, SOURCE: Expert Opinion on Investigational Drugs - Expert Opin. Investig. Drugs, VOLUME: 18, ISSUE: 2
INDEXED IN: CrossRef
IN MY: ORCID
482
TITLE: Alternative therapics and Parkinson's disease in Portugal
AUTHORS: Gouveia, LO; Noronha, A; Finisterra, M; Coelho, M; Rosa, MM; Sampaio, C; Ferreira, JJ;
PUBLISHED: 2009, SOURCE: MOVEMENT DISORDERS, VOLUME: 24
INDEXED IN: WOS
IN MY: ORCID
483
TITLE: "Espresso coffee" for the treatment of excessive daytime sleepiness in Parkinson's disease: Results of four pilot n-of-one clinical trials
AUTHORS: Ferreira, JJ; Correia Guedes, L; Freire, RA; Coelho, M; Rosa, MM; Rascol, O; Sampaio, C;
PUBLISHED: 2009, SOURCE: MOVEMENT DISORDERS, VOLUME: 24
INDEXED IN: WOS
IN MY: ORCID
484
TITLE: A systematic review of the incidence of fatigue as an adverse event in placebo-controlled trials for Parkinson's disease
AUTHORS: Ferreira, JJ; Teodoro, T; Pires, D; Mestre, T; Coelho, M; Rosa, MM; Sampaio, C;
PUBLISHED: 2009, SOURCE: MOVEMENT DISORDERS, VOLUME: 24
INDEXED IN: WOS
IN MY: ORCID
485
TITLE: Therapeutics for Huntington's disease: a systematic review  Full Text
AUTHORS: Mestre, TA; Ferreira, JJ; Coelho, M; Rosa, MM; Sampaio, C;
PUBLISHED: 2008, SOURCE: 12th Congress of the European-Federation-of-Neurological-Societies in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 15
INDEXED IN: WOS
486
TITLE: A 2-year open-label study of botulinum toxin type B in botulinum toxin type A resistant/responsive cervical dystonia patients (AN072-401 EUICD)  Full Text
AUTHORS: Peter Moore; Joaquim Ferreira; Eric Pappert;
PUBLISHED: 2008, SOURCE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXED IN: WOS
IN MY: ORCID
487
TITLE: Is treatment of cervical dystonia patients with botulinum toxin type B affected by a previous response to a botulinum toxin type A? Analysis of a long-term open-label study (AN072-401 EU/CD)  Full Text
AUTHORS: Peter Moore; Joaquim Ferreira; Terry Germanson; Eric Pappert;
PUBLISHED: 2008, SOURCE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXED IN: WOS
IN MY: ORCID
488
TITLE: Botulinum toxin type A (Botox) versus botulinum toxin type B (Myobloc) in subjects with cervical dystonia: A comparison of the frequency of xerostomia and dysphagia (AN072-402 EU/CD)  Full Text
AUTHORS: Eric Pappert; Terry Germanson; Peter P Moore; Joaquim Ferreira;
PUBLISHED: 2008, SOURCE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXED IN: WOS
IN MY: ORCID
489
TITLE: The effects of repeated dosing of botulinum toxin type B (neurobloc (R)) in patients with cervical dystonia previously naive to botulinum toxin: An open-label extension study (AN072-402 EU/CD)  Full Text
AUTHORS: Joaquim Ferreira; Peter Moore; Eric Pappert;
PUBLISHED: 2008, SOURCE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXED IN: WOS
IN MY: ORCID
490
TITLE: A double-blind, randomised, placebo-controlled trial to investigate the efficacy and safety of nebicapone in levodopa-treated Parkinson's disease patients with motor fluctuations
AUTHORS: Ferreira, JJ; Rascol, O; Poewe, W; Sampaio, C; Rocha, F; Nunes, T; Almeida, L; Soares da Silva, P ;
PUBLISHED: 2008, SOURCE: 12th International Congress of Parkinsons Disease and Movement Disorders in MOVEMENT DISORDERS, VOLUME: 23, ISSUE: 1
INDEXED IN: WOS
IN MY: ORCID
Página 49 de 55. Total de resultados: 548.

Um espaço para investigadores e suas instituições

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service